Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Gross Margin: 2014-2025

Historic Gross Margin for CytomX Therapeutics (CTMX) over the last 11 years, with Sep 2025 value amounting to 100.00%.

  • CytomX Therapeutics' Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, CytomX Therapeutics' Gross Margin stood at 100.00%, which was down 0.00% from 100.00% recorded in Q2 2025.
  • CytomX Therapeutics' 5-year Gross Margin high stood at 100.00% for Q1 2021, and its period low was 100.00% during Q1 2021.
  • Moreover, its 3-year median value for Gross Margin was 100.00% (2025), whereas its average is 100.00%.